ID: ALA606040

Max Phase: Preclinical

Molecular Formula: C22H16N4OS

Molecular Weight: 384.46

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccccc1/C=C/c1cn2c(-c3ccc4ccccc4n3)nnc2s1

Standard InChI:  InChI=1S/C22H16N4OS/c1-27-20-9-5-3-7-16(20)10-12-17-14-26-21(24-25-22(26)28-17)19-13-11-15-6-2-4-8-18(15)23-19/h2-14H,1H3/b12-10+

Standard InChI Key:  LEILYYNQIOHZQI-ZRDIBKRKSA-N

Associated Targets(Human)

Hypoxia-inducible factor 1-alpha inhibitor 79 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 384.46Molecular Weight (Monoisotopic): 384.1045AlogP: 5.19#Rotatable Bonds: 4
Polar Surface Area: 52.31Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 0.05CX LogP: 4.72CX LogD: 4.72
Aromatic Rings: 5Heavy Atoms: 28QED Weighted: 0.43Np Likeness Score: -1.15

References

1. Ko S, Lee MK, Shin D, Park H..  (2009)  Structure-based virtual screening approach to the discovery of novel inhibitors of factor-inhibiting HIF-1: identification of new chelating groups for the active-site ferrous ion.,  17  (22): [PMID:19822432] [10.1016/j.bmc.2009.09.034]

Source